Research Article |
Corresponding author: Hanna I. Severina ( severina.ai@ukr.net ) Academic editor: Alexander Zlatkov
© 2024 Sergiy V. Vlasov, Oleksandr V. Borysov, Hanna I. Severina, Vitaliy S. Vlasov, Amjad Ibrahim M. Abu Sharkh, Victoriya A. Georgiyants.
This is an open access article distributed under the terms of the Creative Commons Attribution License (CC BY 4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Citation:
Vlasov SV, Borysov OV, Severina HI, Vlasov VS, Abu Sharkh AIM, Georgiyants VA (2024) Synthesis, in silico and in vitro antimicrobial activity of N-(benzyl)-5-methyl-4-oxo-3,4-dihydrothieno[2,3- d]pyrimidine-6-carboxamides. Pharmacia 71: 1-9. https://doi.org/10.3897/pharmacia.71.e110013
|
According to the recent studies bezylcarboxamide fragment attached to the thiophene ring of thieno[2,3-d]pyrimidine is beneficial for antimicrobial activity of the compounds. Therefore we focused our efforts on constructing of the simple molecules such as N-(benzyl)-5-methyl-4-oxo-3,4-dihydrothieno[2,3-d]pyrimidine-6-carboxamides to get deeper insight into their antimicrobial activity. As the optimal procedure for preparation of target compounds we choose 1,1’-carbonyldiimidazole promoted interaction of 5-methyl-4-oxo-3,4-dihydrothieno[2,3-d]pyrimidine-6-carboxylic acid with the series of substituted benzyl amines. The obtained amides showed good activity against the strains of S. aureus and B. subtilis, which was higher for the derivative without substituents in benzene ring or the compounds with small substituents like methyl or methoxyl groups in the para-position of the benzene ring. Docking studies showed that despite the good values of the scoring functions, the conformational analysis of the ligands’ poses in the active site revealed their ability for only partial inhibition of TrmD of P. aeruginosa.
thiophene, pyrimidine, amides, coupling, docking, antimicrobials
Thieno[2,3-d]pyrimidines are well known due to their antimycobacterial (
Thieno[2,3-d]pyrimidine-6-carboxylic acids and their benzylamides have attracted attention as biologically active compounds for many years, but the number of publications on their activity is relatively small. The authors of the paper (
As part of research on the development of synthetic methods, the authors (
In our recent research we revealed the promising antimicrobial activity for benzyl amides of 4,5-dimethylthienopyrimidines V, which were active against B. subtilis and P. aeruginosa and their mechanism of action was possibly due to the inhibition of TrmD (
In order to check whether 4-oxo group might have been also beneficial in the structure of thieno[2,3-d]pyrimidin-6-carboxamides with benzyl fragments at amide substituent we decided to obtain the series of simply substituted N-(benzyl)-5-methyl-4-oxo-3,4-dihydrothieno[2,3-d]pyrimidine-6-carboxamides and test their antimicrobial activity with parallel docking studies to TrmD. Taking into account the low reactivity of the ester group in the ethyl 5-methyl-4-oxo-3,4-dihydrothieno[2,3-d]pyrimidine-6-carboxylate, which complicated direct interaction with benzylamine, we decided to consider the possibility of using peptide couplings-reagents that allow easy synthesis of amides starting from carboxylic acids (
All solvents and reagents were obtained from commercial sources. The melting points were determined in a capillary using an electrothermal IA9100X1 (Bibby Scientific Limited, Staffordshire, UK) digital melting point apparatus. The elemental analyses were performed on a Euro Vector EA-3000 (Eurovector SPA, Redavalle, Italy) microanalyzer and were within 0.4% of the theoretical values. 1H NMR spectra for the compounds 5.1, 5.2, 5.3 and 5.5 were recorded on Bruker Avance DRX 500 500 MHz spectrometers, respectively; 13C NMR spectra - on a Bruker Avance DRX 500 spectrometer at 125 MHz, respectively, solvents - DMSO-d6, internal standard TMS (1Н, 13C). For the compound 5.4 1H and 13C NMR spectra were acquired by Varian-600 at 600 MHz and 150 MHz respectively. LC/MS spectra were recorded on Agilent 1100 HPLC instrument equipped with diode matrix and mass detectors (Agilent LC- MSD SL), column Zorbax SB-C18 (4.6 mm × 15 mm). Atmospheric Pressure Chemical Ionization (APCI) was used in the experiment.
4-Oxo-5-methylthieno[2,3-d]pyrimidine-6-carboxylic acid was prepared according to the previously reported procedure (
To 0.25 g (0.00118 mol) of 4-oxo-5-methylthieno[2,3-d]pyrimidine-6-carboxylic acid and 0.195 g (0.0012 mol) of 1,1’-carbonyldiimidazole 1 ml of anhydrous dimethylformamide was added. The reaction mixture was heated at 50 °C for 10 minutes until the release of carbon dioxide was complete. Then to 0.0012 mole of the corresponding amine was added to the resulting solution of 4-oxo-5-methylthieno[2,3-d]pyrimidine-6-carboxylic acid imidazolide and the reaction flask was tightly closed to protect against moisture. The reaction mixture was heated at 80 °C for 3 hours. Then the reaction mixture was cooled and quenched with water to form the crystalline product. The precipitate formed was filtered off and washed with plenty of cold water. The products were additionally crystallized from ethanol.
Yield – 0.293 g (83%), white crystals. M. p. 224–225 °С. Anal. Calcd. for C15H13N3O2S, % (299.34): C, 60.19; H, 4.38; N, 14.03. Found, C, 60.12; H, 4.45; % N, 14.17. 1H NMR (500 MHz, DMSO-d6) δ, ppm: 2.70 (s, 3H, СН3), 4.43 (d, 2Н, J = 5.2 Hz, CH2), 7.28–7.36 (m,4Н, Ar-H), 8.14 (d, 1H, J = 4.8 Hz, CH), 8.75 (t, 1H, J = 4.6 Hz, NH amide), 12.53 (d, 1H, J = 4.6 Hz, NH pyrimidine). 13C NMR (125 MHz, DMSO-d6) δ, ppm: 14.9; 42.8; 123.5; 126.8; 127.2; 127.6; 128.3; 136.1; 139.2; 147.2; 158.3; 161.9; 163.9. LC-MS m/z (ES+) 300.0 (MH+).
Yield – 0.262 g (71%), white crystals. M. p. 246–247 °С. Anal. Calcd. for C16H15N3O2S, % (313.37): C, 61.32; H, 4.82; N, 13.40. Found, % C, 61.41; H, 4. 4.88; N, 13.51. 1H NMR (500 MHz, DMSO-d6) δ, ppm: 2.26 (s, 3H, СН3), 2.68 (s, 3H, СН3), 4.37 (d, 2Н, J = 5,5 Hz, CH2), 7.12 (d, 2H, J = 7,5 Hz, ArH), 7.19 (d, 2H, J = 7.8 Hz, ArH), 8.13 (s, 1H, CH), 8,71 (t, 1H, J = 5,2 Hz, NH amide), 12,52 (s, 1H, NHpyrimidine). 13C NMR (125 MHz, DMSO-d6) δ, ppm: 14.9; 20,6; 42.6; 96.8; 118.9; 123.5; 127.3; 128.8; 136.2; 147.2; 149.6; 152.3; 158.3; 163.9. LC-MS m/z (ES+) 314.0 (MH+).
Yield – 0.307 g (79%), white crystals. M. p. 209–210 °С. Anal. Calcd. for C16H15N3O3S, % (329.37): C, 58.35; H, 4.59; N, 12.75. Found, % C, 58.44; H, 4.60; N, 12.88. 1H NMR (500 MHz, DMSO-d6) δ, ppm: 2,68 (s, 3H, СН3), 3,71 (s, 3H, OСН3), 4,35 (d, 2Н, J = 4,3 Hz, CH2), 6,88 (d, 2H, J = 8,5 Hz, ArH), 7,24 (d, 2H, J = 8,2 Hz, ArH), 8,13 (s, 1H, CH), 8.69 (br. s, 1H, NH amide), 12.52 (s, 1H, NHpyrimidine). 13C NMR (125 MHz, DMSO-d6) δ, ppm: 14.9; 42.3; 55.0; 113.7; 123.5; 127.8; 128.6; 131.1; 136.0; 147.2; 158.2; 158.3; 161.7; 163.9. LC-MS m/z (ES+) 330.0 (MH+).
Yield – 0.247 g (66%), white crystals. M. p. 235–236 °С. Anal. Calcd. for C15H12FN3O2S, % (317.33): C, 56.77; H, 3.81; N, 13.24. Found, % C, 56.82; H, 3.83; N, 13.25. 1H NMR (500 MHz, DMSO-d6) δ, ppm: 2.69 (s, 3H, СН3), 4.40 (d, 2Н, J = 4.6 Hz, CH2), 7.11–7.18 (m, 2H, Ar-H), 7.31–7.38 (m, 2H, ArH), 8.13 (s, 1H, CH), 8.75 (br. s, 1H, NHamide), 12.52 (br. s, 1H, NHpyrimidine). 13C NMR (125 MHz, DMSO-d6) δ, ppm: 15.42; 42.66; 115.42; 115.55; 124.01; 127.97; 129.71; 129.76; 135.86; 135.88; 136.74; 147.71; 158.81; 160.83; 162.36; 162.44; 164.42. LC-MS m/z (ES+) 318.0 (MH+).
Yield – 0.299 g (69%), white crystals. M. p. 255–256 °С. Anal. Calcd. for C15H11Cl2N3O2S, % (368.23): C, 48.93; H, 3.01; N, 11.41. Found, % C, 49.03; H, 3.12; N, 11.58. 1H NMR (500 MHz, DMSO-d6) δ, ppm: 2.70 (s, 3H, СН3), 4.41 (d, 2Н, J = 5.2 Hz, CH2), 7.31 (d, 1H, J = 8,2 Hz, Ar-H), 7.53–7.62 (m, 2H, ArH), 8.14 (s, 1H, CH), 8.78 (br. s, 1H, NHamide), 12.52 (br.s, 1H, NHpyrimidine). 13C NMR (125 MHz, DMSO-d6) δ, ppm: 14.9; 41.9; 123.6; 127.1; 127.7; 129.3; 130.5; 130.8; 136.6; 140.5; 147.3; 158.3; 162.0; 164.0. LC-MS m/z (ES+) 370.0 (MH+).
The study of the antimicrobial activity of the synthesized compounds was carried out at the Laboratory of Biochemistry of Microorganisms and Nutrient Media of the Mechnikov Institute of Microbiology and Immunology of the NAMS of Ukraine (Kharkiv) under the supervision of Candidate of biological sciences, senior researcher T. P. Osolodchenko.
The antimicrobial activity of the obtained compounds was evaluated in accordance with WHO recommendations (
For the agar well diffusion method, the microbial load was 107 microbial cells per 1 ml of medium and was determined according to the McFarland standard (
When assessing the antimicrobial activity of the compounds, the following criteria were used (
Molecular docking was performed using the AutoDock Vina and AutoDockTools 1.5.6 programs. A macromolecule from the PDB (
The first step of the synthetic scheme is the hydrolysis of ethyl 5-methyl-4-oxo-3,4-dihydrothieno[2,3-d]pyrimidine-6-carboxylate (
For the coupling of 5-methyl-4-oxo-3,4-dihydrothieno[2,3-d]pyrimidine-6-carboxylic acid with the series of benzylamines we used 1,1’-carbonyldiimidazole which showed its high efficacy in our recent research (
The synthetic scheme in this case requires a two-stage procedure. At the first stage, a DMF soluble imidazolide is generated by mixing 5-methyl-4-oxo-3,4-dihydrothieno[2,3-d]pyrimidine-6-carboxylic acid with a coupling reagent in dimethylformamide under slight heating, this process usually lasts 10–15 minutes. At the second stage, the corresponding amine is added directly to the same reactor without significant changes in the regime. In this way, both stages of the process can be performed one-pot, which makes the scheme more economical. The procedure does not require high temperature or pressure. Moreover, their isolation is achieved by diluting the reaction mixture with water.
The structure of all obtained target benzylamides of 5-methyl-4-oxo-3,4-dihydrothieno[2,3-d]pyrimidine-6-carboxylic acid 5 was confirmed using a number of modern instrumental methods of analysis.
According to the data of 1H NMR spectroscopy, all the obtained amides are characterized by signals of amide NH protons in the range of 8.69–8.78 ppm, which has the form of a triplet, indicating its proximity to the methylene group of the benzylic fragment. The signal of the last group has the form of a doublet and is observed in the range of 4.35–4.43 ppm.
All amides have the typical signal of the NH group in position 3 of the dihydrothieno[2,3-d]pyrimidine system, which is observed in the range of 12.52–12.53 ppm. and has the appearance of a broaden singlet. Spectral data show that the chemical shift of this signal depends little on the type of the substituent in the amide fragment, which additionally indicates the proper assignment of this signal. The presence of a pyrimidine ring with a free position 2 is evidenced by the presence of a clear CH signal in the range of 8.13–8.14 ppm, which appears as a sharp singlet. The signals of the methyl group of the thiophene nucleus are observed as a singlet in the range of 2.68–2.70 ppm.
The obtained compounds 5 has a clear pattern of signals, which corresponds to the substitution of the aromatic part of the benzyl amide fragment. Thus, in the case of N-benzyl-5-methyl-4-oxo-3,4-dihydrothieno[2,3-d]pyrimidine-6-carboxamide 5.1, the following pattern of signals are observed in the resonance region of aromatic protons 7.28–7.36 (m, 4Н, Ar) and 8.14 (d, 1H, J = 4.8 Hz, CH). For 5-methyl-N-(4-methylbenzyl)-4-oxo-3,4-dihydrothieno[2,3-d]pyrimidine-6-carboxamide 5.2 and N-(4-methoxybenzyl)-5-methyl-4-oxo-3,4-dihydrothieno[2,3-d]pyrimidine-6-carboxamide 5.3 the signals typical for AA’BB’ systems, such as two groups of doublet signals are observed in at 7.12 (d, 2H, J = 7.5 Hz) and 7.19 (d, 2H, J = 7.8 Hz) for the methyl derivative 5.2 while for the methoxy derivative 5.3 the signals are at 6.88 (d, 2H, J = 8.5 Hz) and 7.24 (d, 2H , J = 8.2 Hz) correspondingly.
The CH3 signal of the substituent is in the spectrum of amide 5.2 is at 2.26 (s, 3H, CH3), and the methoxy group signal of the compound 5.3 is at 3.71 (s, 3H, OCH3). The presence of such a substituent as a fluorine atom in 5-methyl-4-oxo-N-(4-fluorobenzyl)-3,4-dihydrothieno[2,3-d]pyrimidine-6-carboxamide 5.4 contributes to the splitting of the signals of aromatic protons and they appear as a multiplet 7.11–7.18 (m, 2H, Ar-H), 7.31–7.38 (m, 2H, Ar-H). In the spectrum of 3,4-dichlorosubstituted derivative 5.5, the aromatic proton signals have the following form: 7.31 (d, 1H, J = 8.2 Hz, Ar-H), 7.53–7.62 (m, 2H, Ar-H).
In order to evaluate the structure and purity of the compounds, the method of liquid chromatography-mass spectrometry (LC-MS) was used, which allowed us to confirm the purity of the obtained samples and to prove that the molecular weight of the obtained samples corresponds to the suggested structures.
We used the 13C NMR spectroscopy method, which clearly showed the presence of the appropriate number of carbon atoms for each sample of amides 5 and allowed us to confirm the presence of fragments that contain groups with carbon atoms as substituents. Thus, signals of CH3 groups in the thiophene nucleus are observed at 14.9 ppm. The signals of the CH2 groups is observed in the region 41.9–42.8 ppm and their position depends much on the substituent. For 5-methyl-N-(4-methylbenzyl)-4-oxo-3,4-dihydrothieno[2,3-d]pyrimidine-6-carboxamide, the signal of the methyl group at the phenyl ring is observed at 20.6 ppm, and the signal of the methoxy group for N-(4-methoxybenzyl)-5-methyl-4-oxo-3,4-dihydrothieno[2,3-d]pyrimidine-6-carboxamide 5.3 it is present at 55.0 ppm.
The study of antimicrobial activity against standard strains of microorganisms has been carried out for the synthesized N-benzylamides of 4-oxo-5-methylthieno[2,3-d]pyrimidine-6-carboxylic acid 5. The study was conducted in comparison with the drug Meropenem, which is a modern and very effective antibiotic. The results of the research are presented in Table
Antibacterial activity of N-(benzyl)-5-methyl-4-oxo-3,4-dihydrothieno[2,3-d]pyrimidine-6-carboxamides 5.1–5.5.
Compound/R | Diameters of zones of growth retardation in mm, number of repetitions of the experiment, n = 3 | |||||
---|---|---|---|---|---|---|
Staphylococcus aureus АТСС 25923 | Escherichia coli АТСС 25922 | Proteus vulgaris ATCC 4636 | Pseudomonas aeruginosa АТСС 27853 | Bacillus subtilis АТСС 6633 | Candida albicans ATCC 653/885 | |
5.1/H | 24, 23, 24 | 23, 23, 24 | 21, 22, 21 | 22, 22, 22 | 24, 24, 24 | 20, 21, 21 |
5.2/4-CH3 | 22, 23, 23 | 20, 21, 20 | 20, 21, 21 | 21, 21, 22 | 23, 24, 23 | 17, 16, 17 |
5.3/4-OCH3 | 23, 22, 22 | 20, 21, 21 | 19, 19, 19 | 20, 20, 20 | 23, 24, 23 | 18, 17, 17 |
5.4/4-F | 19, 21, 21 | 19, 20, 20 | 19, 20, 19 | 21, 20, 20 | 21, 22, 23 | 18, 18, 18 |
5.5/3,4-diCl | 22, 21, 22 | 20, 21, 20 | 18, 19, 19 | 19, 19, 19 | 22, 22, 22 | 17, 19, 18 |
Mepenam | 35, 34, 34 | 31, 32, 32 | 30, 30, 31 | 32, 32, 32 | 35, 34, 35 | 15, 14, 15 |
To predict the possible mechanism of antibacterial action of target thienopyrimidine derivatives 5, molecular docking was carried out in the active site of selective inhibitors of tRNA (Guanine37-N1)-methyltransferase (TrmD) isolated from P. aeruginosa (
The studied thienopyrimidines demonstrated different degrees of affinity to the TrmD inhibitor site (Table
Docking results of N-substituted benzyl-5-methyl-4-oxo-thieno[2,3-d]pyrimidine-6-carboxamide 5.1-5.5 in the active site of the inhibitor TrmD isolated from P. aeruginosa.
Ligand | Binding energy kcal/mol | Hydrophobic interaction | Hydrogen interaction | Other interaction |
---|---|---|---|---|
Native ligand | -8.2 | Tyr141, Ser93(2)#, Pro94 (4), Pro149(2), Ile138, Leu143, Gly145, Gly146 | Leu143, Gln95, Glu121, Gly139, Asp182 | - |
5.1 / H | -9.7 | Ser93, Pro94(5), Tyr91*, Leu143, Pro149, | Tyr91*, Asp182 | - |
5.2 / 4-CH3 | -9.7 | Ser93, Pro94(5), Leu92*, Ile138 Pro149(2), Tyr91*, Leu143 | Asp182(2), Pro94 | - |
5.3 / 4-OCH3 | -9.4 | Ser93, Pro94(4), Gly145, Gly146, Val142*, Leu143, Pro149 | Ile138, Asp182, Gly145, Trp136* | - |
5.4 / 4-F | -10.1 | Ser93, Pro94(5), Tyr91*, Leu143, Pro149 | Tyr91*, Ile138, Ser137*, Asp182 | Trp136* Halogen |
5.5 / 3,4-диCl | -10.1 | Ser93, Pro94(5), Gly145, Gly146, Ile138(2), Leu92*, Pro149(2), Tyr91, Leu143 | Gln95, Asp182(2), Pro94, Ser137* | Trp136* Halogen |
For all studied benzylamide derivatives, a high degree of affinity to the site of the TrmD inhibitor was calculated, which exceeds the affinity of the native reference ligand: from -9.7 to -10.1 kcal/mol relative to -8.2 kcal/mol, respectively. The best affinity vales were predicted for derivatives 5.4 and 5.5 substituted by halogen in the benzyl radical.
The possibility of forming a stable conformation with a branched network of hydrophobic interactions and additional fixation by hydrogen bonds was recorded (Fig.
Additional prediction of Halogen Acceptor interactions of chlorine atom (compound 5.5) and fluorine atom (compound 5.4) with the carbonyl group of tryptophan (Trp136) can explain the better values of their scouring functions (Table
The suggested procedure for N-(benzyl)-5-methyl-4-oxo-3,4-dihydrothieno[2,3-d]pyrimidine-6-carboxamides synthesis starting form readily available 4-oxo-5-methylthieno[2,3-d]pyrimidine-6-carboxylic acid was found to be highly effective and produced us the target molecules with high yields and high purity. The results of antimicrobial activity screening showed that most amides 5 have high antimicrobial activity against the strain of Staphylococcus aureus and Bacillus subtilis and their antimicrobial activity against Pseudomonas aeruginosa is lesser. Moreover, compounds with an unsubstituted benzene ring or light substituents such as methyl (-CH3) or methoxyl (-OCH3) groups in the para-position of the benzene nucleus turned out to be the most active in relation to all of the bacterial strains. The expected activity against Pseudomonas aeruginosa strain was not as high as the activity of the previously reported 4-thieno[2,3-d]pyrimidine analogues (
A series of N-benzylamides of 4-oxo-5-methylthieno[2,3-d]pyrimidine-6-carboxylic acid were synthesized by peptide coupling the starting acid with substituted benzylamines upon its activation with 1,1’-carbonyldiimidazole. The study of the antimicrobial activity of N-benzylamides of 4-oxo-5-methylthieno[2,3-d]pyrimidine-6-carboxylic acid by the agar-well diffusion method showed their high activity against the strain of Staphylococcus aureus and Bacillus subtilis and lesser activity against Pseudomonas aeruginosa. The compounds with an unsubstituted benzene ring or light substituents such as methyl (-CH3) or methoxyl (-OCH3) groups in the para-position of the benzene nucleus were most active against both strains. Docking studies to the active site of TrmD inhibitors isolated from P. aeruginosa showed that despite the good values of the scoring functions, the conformational analysis indicated the ability for moderate inhibition of TrmD of P. aeruginosa.
The suggested methods for synthesis of benzylamides and the docking to TrmD can be applied for more thieno[2,3-d]pyrimidine-6-carboxylic acids as the starting compounds for preparation of the novel series of benzyl amides suitable for the development of new antimicrobials.
The authors acknowledge Enamine Ltd. for the measurement of 1H, 13C NMR and LC-MS spectra of the obtained substances. We are grateful to T.P. Osolodchenko (Mechnikov Institute of Microbiology and Immunology of the NAMS of Ukraine, Kharkiv, Ukraine) for her assistance in carrying out antimicrobial research.
The research was funded by the Ministry of Health Care of Ukraine at the expense of the State Budget in the framework # 2301020 “Scientific and scientific-technical activity in the field of health protection” on the topic “Synthesis and study of new thienopyrimidines for the detection of antimicrobial and related types of pharmacological activity” (Order of the Ministry of Health of Ukraine of November 17, 2020 № 2651).